|
|
16th Annual Essentials in Primary Care Summer Conference
Experience the perfect balance of professional growth and leisure at the 16th Annual Essentials in Primary Care Summer Conference, hosted at the Hammock Beach Resort in Palm Coast, Florida. With half-day morning sessions dedicated to expanding your medical knowledge, attendees have ample time in the afternoons to unwind and explore the natural wonders of Palm Coast's pristine coastline and inland havens, including eco-tours through lush marshlands, tee times on championship golf courses, ... |
|
|
Lp(a) and LDL-C Management: Exploring Divergent Perspectives
Target Audience
The intended audience for this activity is cardiologists, endocrinologists, internists, pharmacists, nurses, and other healthcare professionals involved in the management of patients with hyperlipidemia and other cardiovascular risk factors.
Program Overview
Lp(a) and LDL-C Management: Exploring Divergent Perspectives is a continuing education (CE) initiative aimed at broadening healthcare professionals' understanding of the complex nature of hyperlipidemia management... |
|
|
Thyroid Eye Disease Mastery: Multidisciplinary Approaches to Diagnosis and Treatment
Thyroid eye disease (TED) is a multifactorial autoimmune disease with widely varied signs and symptoms. It is believed to result from the stimulation of several receptors located in the orbital fibroblasts and is usually associated with hyperthyroidism. However, 5% of patients with TED have hypothyroidism, and 5% have no sign of thyroid disease; thus, it is frequently misdiagnosed. Misdiagnosis can place patients at risk for disfigurement and permanent vision loss, because treatment is most ef... |
|
|
Addressing Underutilization of Cardioprotective GLP-1 RAs for T2D in Specialty Practice.
The complexity of patients with T2D combined with the overwhelming amount of outcomes data complicates the treatment decision matrix exponentially and clinical inertia persists. This self-paced, interactive education includes a learning assessment followed by customizable content repository designed to sharpen your ability to individualize therapeutic targets and glucose-lowering regimens based on multiple factors, including the presence of comorbidities, such as obesity or cardiovascular risk... |
|
|
Are You Up to Speed? Test Your Knowledge on Pneumococcal Vaccination in Adults
Despite widespread availability of pneumococcal vaccines designed to reduce the risks for infection and invasive pneumococcal disease, coverage remains suboptimal among older adults and those with underlying medical conditions and risk factors. The development of pneumococcal conjugate vaccines offers new opportunities for improved protection against pneumococcal disease, but are you current with the latest evidence and guideline recommendations? If you're a puzzle enthusiast, dive into t... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Mastering Suboptimal Treatment Response in nAMD
In this Master Class case, Dr. David Eichenbaum discusses the management of a 69-year-old White man with neovascular age-related macular degeneration who receives a suboptimal treatment response to initial anti-vascular epithelial growth factor therapy. |
|
|
Mastering Suboptimal Treatment Response in DME
In this Master Class case, Dr. W. Lloyd Clark discusses the management of a 75-year-old Black woman with diabetic macular edema who has a suboptimal treatment response to initial anti-vascular epithelial growth factor therapy. |
|
|
Navigating the Evolving Standards of Newly Diagnosed Multiple Myeloma Treatment: Exploring the Evidence on New Combination Strategies
ACTIVITY DESCRIPTION
The goal of treatment for newly diagnosed multiple myeloma (NDMM) patients is achieving the deepest possible remission, which typically involves aiming for minimal residual disease negativity. Frontline therapy for NDMM is evolving to include novel induction regimens with anti-CD38 antibodies, which have been shown to yield improved depth of response after induction. These new frontline treatments vary in induction regimen composition and use of transplant, consolidation,... |
|
|
Podcast: Multidisciplinary Task Force and Position Statement: Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory Multiple Myeloma
STATEMENT OF NEED
With the complex and rapidly evolving treatment landscape of multiple myeloma, it is vital that clinicians not only understand factors for informing selection of current and emerging combination and sequential therapeutic strategies, but also employ interdisciplinary strategies for reducing disparities in relapsed/refractory multiple myeloma care. The development of novel therapeutic options has significantly improved treatment outcomes for patients with relapsed/refractor... |
|
|
Bridging the Health Gaps in Hereditary Angioedema: Demystifying Disparities, Enhancing Quality of Life, and Implementing Effective Prophylactic Solutions
Hereditary angioedema (HAE) is a rare, life-threatening disorder characterized by recurrent, unpredictable episodes of bradykinin-induced swelling. In this presentation, Dr. Marc Reidl, Clinical Director of the US Hereditary Angioedema Association (HAEA) Angioedema Center, reviews multiple underrecognized factors that contribute to health disparities among patients with HAE, including delays in diagnosis and multifaceted differences among racial and ethnic groups, socioeconomic status levels, ... |
|
|
Best of ACTHIV® 2024: Hypertension and Renal Disease in People with HIV
Description
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2024 conference for the frontline HIV care team, this activity will focus on epidemiology of, and risk factors for renal disease in PWH, evaluating renal function, improving management of hypertension, and working as a team to optimize ARV decisions in PWH and renal dysfunction.
Learning Objectives
Describe the epidemiology of, and risk factors for renal disease in HIV
... |
|
|
nAMD and DME: Novel Treatment Plans to Prioritize Real-World Visual Improvements
Frequent intravitreal injections of anti-vascular endothelial growth factor (VEGF) therapies can significantly improve visual and anatomical outcomes for many patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). However, the requisite high number of treatments often leads to less-than-ideal results compared to outcomes reported in major clinical trials, largely due to the demanding treatment schedule. Adopting tailored treatment plans, along with ... |
|
|
Thyroid Eye Disease: Unmasking and Taming What’s in Disguise
Thyroid eye disease (TED) is a complex autoimmune-mediated inflammatory disorder of the orbit that is associated with a spectrum of signs and symptoms and varying levels of severity. Early diagnosis and initiation of appropriate treatment are imperative for preventing progression to severe disease and potential vision loss. However, diagnosis can be challenging. Traditional treatments for TED, such as steroids, radiotherapy, and surgery, all relieve symptoms but do not alter the course of dise... |
|
|
Overcoming the Hurdles: Advances in the Management of Hemophilia
In this fast-moving, 1-hour accredited activity, Craig Kessler, MD, and Guy Young, MD, share their thoughts and experience with clotting factor concentrates, recombinant factor, factor VIII mimetics, rebalancing agents, and gene therapies. The safety and efficacy of late-phase investigational products are also discussed as these agents have the potential to address unmet needs and further transform patient care. |
|
|
Extending Dosing Intervals in Retinal Disease: Patient Perspectives and Clinical Insights to Guide Your Practice
Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are increasingly prevalent retinal diseases that pose significant challenges in ophthalmic care. While anti-vascular endothelial growth factor (VEGF) therapies have greatly improved visual outcomes for patients with these conditions, real-world data indicate that many patients receive suboptimal treatment and monitoring, resulting in poorer visual outcomes. Newer therapeutic options have been developed to exte... |
|
|
Nutraceuticals for Dry Eye: Dispelling the Dogma and Embracing the Data
Dry eye disease is a common yet frequently overlooked condition that significantly affects quality of life. Despite an estimated global prevalence of up to 50%, DED is often underdiagnosed and inadequately managed. To limit the burden of DED, it is crucial for clinicians to be adept at recognizing risk factors and making accurate diagnoses. In addition, as treatment options expand to include clinically proven nutraceuticals, it is imperative that clinicians stay abreast of the latest clinical ... |
|
|
7th Annual Women's Health Conference
Join women's health professionals from around the country at the 7th Annual Women's Health Conference on September 29 - October 1, 2025, at the Sheraton New Orleans.
Elevate your medical practice amidst the Old World feel of New Orleans at the 7th Annual Women's Health Conference. Nestled in the heart of Canal Street (streetcar line) across from the French Quarter, the Sheraton New Orleans offers opportunities for primary care professionals to engage in continuing medical edu... |
|
|
HER3 in NSCLC " Navigating New Frontiers in Targeted Therapy
In patients with non-small cell lung cancer (NSCLC), human epidermal growth factor receptor 3 (HER3) is associated with both advanced disease and resistance to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)"directed therapies. Although there are therapeutic options targeting EGFR (HER1) and HER2, the potential of HER3 as an anti-cancer target has been largely overlooked. Overexpression of HER3 in most patients with NSCLC positions it as an appealing therapeutic targ... |
|
|
15th Annual Primary Care Fall Conference
Join us for the 15th Annual Primary Care Fall Conference, a variety of medical insights set against the backdrop of Maui's natural splendor on Ka'anapali Beach at the Sheraton Maui Resort & Spa. This event invites Family and Internal Medicine Physicians, Nurse Practitioners, and Physician Assistants to delve into practical medical insights while soaking in the essence of Hawaiian paradise. With a half-day CME schedule, attendees can seamlessly weave professional development with... |
|
|
THE MICRONUTRIENTS: Vitamin A & Carotenoids
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone pass... |
|
|
THE MICRONUTRIENTS: Survey of 13 Vitamins, Deficiencies, Supplements, and Interactions (Home Study Bundle)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
The Retina Radar With Dr. Arshad Khanani on DR, GA, New Mechanisms, and Noninvasive Treatments
Retinal diseases are a leading cause of global vision impairment, driven by an increasing prevalence and the need for more effective treatment. Although clinical trials have shown promising results for various therapies, real-world application often yields less impressive outcomes due to factors like under-treatment and patient non-adherence. New and emerging therapies, particularly for conditions like diabetic macular edema (DME), diabetic retinopathy, and geographic atrophy (GA) secondary to... |
|
|
Obesity Forum® FAQs: A Podcast Series
Obesity is an increasingly prevalent, chronic condition associated with substantial risks of morbidity and mortality. It is also a risk factor for some of the leading causes of preventable death, including cardiovascular disease, stroke, type 2 diabetes mellitus, sleep apnea, gallbladder disease, osteoarthritis, and certain types of cancer. The 12th Annual Obesity Forum was a 2-part series that provided health care professionals with guidance on the appropriate use of therapies as well as stra... |
|
|
16th Annual Essentials in Primary Care Fall Conference, Session 1
Embark on a medical journey at the 16th Annual Essentials in Primary Care Fall Conference, taking place at the newly renovated Hawks Cay Resort on Duck Key in the enchanting Florida Keys. Delight in the state-of-the-art amenities of this AAA Four-Diamond award-winning resort, surrounded by aquamarine waters, lush landscapes, and a laid-back island vibe. The conference promises a vibrant fusion of top-notch primary care CME education, breathtaking sunrises and sunsets, and the chance to explor... |
|
|
16th Annual Essentials in Primary Care Fall Conference, Session 2
Embark on a medical journey at the 16th Annual Essentials in Primary Care Fall Conference, taking place at the newly renovated Hawks Cay Resort on Duck Key in the enchanting Florida Keys. Delight in the state-of-the-art amenities of this AAA Four-Diamond award-winning resort, surrounded by aquamarine waters, lush landscapes, and a laid-back island vibe. The conference promises a vibrant fusion of top-notch primary care CME education, breathtaking sunrises and sunsets, and the chance to explor... |
|
|
THE MICRONUTRIENTS: Thiamin (B1)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Vitamin E
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Vitamin K
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Vitamin D
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Riboflavin (B2)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Niacin (B3)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Pantothenic (B5)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Vitamin B6
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone pass... |
|
|
THE MICRONUTRIENTS: Biotin (B7)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Folate (B9)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Vitamin B12
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Vitamin C
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
9th Annual National Hospitalist Conference
The 9th Annual National Hospitalist Conference on December 1-4, 2025, at the Wyndham Grand Clearwater Beach is designed to provide attendees with the information and skills to improve the care of hospitalized patients. This conference has been accredited for up to 16 CME credits.
The conference's focus is on the practical management of problems commonly encountered in hospital medicine. An emphasis will be placed on recent advances, up-to-date practices, and guidelines for inpa... |
|
|
What’s New With HER2: Charting New Paths in NSCLC Care - Module 1: HER2 in NSCLC: Actionable Insights and Testing Recommendations
STATEMENT OF NEED
With the identification of oncogenic drivers and the development of targeted therapies, comprehensive molecular assessment has become a cornerstone of non"small cell lung cancer (NSCLC) management. Human epidermal growth factor receptor 2 (HER2) alterations, which include gene mutations, gene amplifications, and protein overexpression, are emerging therapeutic targets. While testing can be used to guide treatment decisions, the heterogeneity of HER2 alterations and th... |
|
|
What’s New With HER2: Charting New Paths in NSCLC Care - Module 2: Current and Emerging Treatments for HER2-Mutated NSCLC
STATEMENT OF NEED
In recent years, the discovery of oncogenic drivers and development of targeted therapies have transformed the treatment of advanced non"small cell lung cancer (NSCLC). Alterations in human epidermal growth factor receptor 2 (HER2), which include gene mutations, gene amplifications, and protein overexpression, are therapeutic targets. Several HER2-targeted therapies are under investigation in NSCLC and have demonstrated clinical benefit, with trastuzumab deruxtecan re... |
|
|
Podcast: What’s New With HER2: Charting New Paths in NSCLC Care - Module 1: HER2 in NSCLC: Actionable Insights and Testing Recommendations
STATEMENT OF NEED
With the identification of oncogenic drivers and the development of targeted therapies, comprehensive molecular assessment has become a cornerstone of non"small cell lung cancer (NSCLC) management. Human epidermal growth factor receptor 2 (HER2) alterations, which include gene mutations, gene amplifications, and protein overexpression, are emerging therapeutic targets. While testing can be used to guide treatment decisions, the heterogeneity of HER2 alterations and th... |
|
|
Podcast: What’s New With HER2: Charting New Paths in NSCLC Care - Module 2: Current and Emerging Treatments for HER2-Mutated NSCLC
STATEMENT OF NEED
In recent years, the discovery of oncogenic drivers and development of targeted therapies have transformed the treatment of advanced non"small cell lung cancer (NSCLC). Alterations in human epidermal growth factor receptor 2 (HER2), which include gene mutations, gene amplifications, and protein overexpression, are therapeutic targets. Several HER2-targeted therapies are under investigation in NSCLC and have demonstrated clinical benefit, with trastuzumab deruxtecan re... |
|
|
6th Annual Medical Updates in Primary Care Conference
Escape to the idyllic Big Island of Hawaii on December 8-12, 2025 for the 6th Annual Medical Updates in Primary Care Conference at the luxurious Fairmont Orchid Resort. Presented by Continuing Education Company, this conference is a haven for primary care clinicians seeking the latest advancements in therapeutic areas. Amidst the breathtaking landscapes of the Big Island, attendees will engage in dynamic sessions focused on practical insights and evidence-based strategies to elevate their prim... |
|
|
Improving Equity in Endometrial Cancer Care and Treatment: Accelerating Change to Improve Patient Outcomes in Rural and Underserved Communities
Target Audience
This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities.
Program Overview
In rural and underserved communities, disparities in incidence, treatment, and prognosis are pervasive among women with endometrial cancer. Key factors contributing to these gaps include limited access to oncology specialty care and lack of familiarity with current therapeut... |
|
|
Evolving Treatment Paradigms in HR+/HER2- Early Breast Cancer: Advancing Equitable Care in Rural and Underserved Communities
Target Audience
This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities.
Program Overview
Hormone receptor"positive, human epidermal growth factor receptor 2"negative (HR+/HER2-) breast cancer accounts for up to 70% of all breast cancer cases. In recent years, therapies such as CDK4/6 inhibitors, PARP inhibitors, and novel endocrine therapies have been ... |
|
|
Targeting the PI3K/AKT/PTEN Pathway for Treatment of Breast Cancer: Innovative Solutions for Equitable Care
Target Audience
This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities.
Program Overview
The PI3K/AKT/PTEN pathway has emerged as a key player in breast cancer development. Notably, up to 50% of patients with hormone receptor"positive, human epidermal growth factor receptor 2"negative (HR+/HER2-) breast cancer have actionable biomarkers within this pat... |
|